Literature DB >> 7370858

Rubella antibody titres and immunization status in a family practice.

D A Mills, K R Parker, C E Evans.   

Abstract

Rubella vaccination status and immunity to rubella were studied in 230 "active patients" aged 8 to 22 years in a teaching family practice by means of a chart review and measurement of the rubella antibody titre in a blood sample. Of the 200 patients who submitted a blood sample 161 (80%) were found to be immune, having a rubella hemagglutination-inhibiting antibody titre of 1:16 or greater. Log linear analysis showed that immunity to rubella was independent of a history of rubella, and that 94% of the vaccinated patients versus 74% of the unvaccinated patients (a significant difference; P = 0.007) were immune. In retrospect we estimated that 80% of the study group were protected at the start of the study. After surveillance and follow-up, with vaccination of 27 of the 39 patients identified as susceptible to rubella, this estimated proportion increased to 90%. The study showed that there is nothing to be gained by asking about a history of rubella but that vaccination against this disease is increasing among children aged 5 to 9 years.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370858      PMCID: PMC1801953     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Present status of measles and rubella immunization in the United States: a medical progress report.

Authors:  S Krugman
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

2.  An evaluation of immunization against rubella.

Authors:  J Mountifield
Journal:  Prim Care       Date:  1978-12       Impact factor: 2.907

3.  Research implications of the Virginia study.

Authors:  I R McWhinney
Journal:  J Fam Pract       Date:  1976-02       Impact factor: 0.493

4.  Failure of rubella immunization among adolescent females.

Authors:  M Nussbaum; E Kaplan; I R Shenker
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

5.  Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.

Authors:  R E Weibel; E B Buynak; A A McLean; M R Hilleman
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

  5 in total
  3 in total

1.  Rubella immunization.

Authors:  R G McAuley
Journal:  Can Med Assoc J       Date:  1983-03-01       Impact factor: 8.262

2.  Rubella vaccination: a course becomes clear.

Authors:  J S Spika; D K Clogg
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

3.  Rubella screening: organization and incentive.

Authors:  S Rowlands; R G Bethel
Journal:  J R Coll Gen Pract       Date:  1982-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.